Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cellular Electrophysiology

Background:

• Connexins form cardiac hemichannels and gap junctions, essential for synchronized cardiac function.
• Normally, gap junctions are open for signal propagation, while hemichannels are closed.
• Pathological conditions can reverse this, closing gap junctions and opening hemichannels, disrupting cardiac homeostasis.

Purpose of the Study:

• To review the role of connexin hemichannels in cardiac arrhythmias.
• To explore the molecular mechanisms of connexin-43 hemichannel opening.
• To discuss therapeutic strategies targeting hemichannels and gap junctions in heart disease.

Main Methods:

• Review of experimental evidence on hemichannel function in cardiomyocytes.
• Analysis of molecular control of connexin-43 hemichannel opening.
• Discussion of pharmacological tools for selective hemichannel inhibition and gap junction modulation.

Main Results:

• Hemichannels contribute to pro-arrhythmic events in both ventricular and atrial cardiomyocytes.
• Pathological hemichannel opening perturbs cardiac function and homeostasis.
• Selective inhibition of hemichannels and preservation of gap junctions show therapeutic potential.

Conclusions:

• Connexin hemichannels play a significant role in cardiac arrhythmias.
• Targeting hemichannel opening and maintaining gap junction function is a promising therapeutic strategy for heart disease.
• Further research into connexin-based approaches is crucial for developing novel treatments.